🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-525122-35-00
Authorised Phase IV

Attachment Development and Learning in ADHD: The Role of Dopamine.

2025-525122-35-00 · tracked via the Priya Life Science EU tracker
Sponsor
UZ Leuven
Sponsor type
Hospital/Clinic/Other health care facility
Therapeutic area
Mental Disorders
Decision date
15/09/2026
Enrollment target
64
Sites
Belgium

Condition studied

Attention-Deficit/Hyperactivity Disorder (ADHD)

Investigational medicinal product(s)

Description: Whiteroundflatwith beveled edges. One side bears the imprint "CG"the other “A/B" and score. May contain dark specks. Diameter: about 7.0 mm.Thickness: about 2.6 mm. Composition: Ingredient Amount per tablet [mg] Function Reference Wheat starch 5169 DiluentBinderDisintegrant Ph. Eur. Lactosemonohydrate 4308 Diluent Ph. Eur. Calcium phosphatetribasic 3769 Diluent Ph. Eur. Waterpurified1 - - Ph. Eur. Talc 603 Glidant Ph. Eur. Gelatin 108 Binder Ph. Eur. Magnesium stearate 043 Lubricant Ph. Eur. Total weight 1400 Packaging: PA/AL/PVC blister pack backed with a heat-sealable lacquered aluminum foil. The manufacturing process of the tablets consists of a traditional wet granulation process which is carried out according to standard pharmaceutical procedures of wettingmassing/kneadingdryingsievingmixing and tableting.Rilatine 10 mg Tabletten

Eligibility

Age group
0-17 years
Sex
Female, Male

Primary endpoint

Children’s instrumental responding to caregiver-related cues compared to neutral cues; children’s trust learning and support-seeking behavior; behavioral-based rating of children’s attachment representations and parental sensitivity; immediate affective relationship dynamics.

Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-525122-35-00 on CTIS ↗ ← All trials in the EU